Hematopoietic stem cell transplantation from haploidentical offspring donors using post-transplant cyclophosphamide versus human leukocyte antigen-matched siblings in older patients with myelodysplastic syndrome

Am J Hematol. 2024 Feb;99(2):E42-E45. doi: 10.1002/ajh.27160. Epub 2023 Nov 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Cyclophosphamide / therapeutic use
  • Graft vs Host Disease*
  • HLA Antigens / genetics
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Myelodysplastic Syndromes* / therapy
  • Siblings
  • Tissue Donors
  • Transplantation Conditioning
  • Unrelated Donors

Substances

  • Cyclophosphamide
  • HLA Antigens